Dietary Supplement Use and Patient Outcomes in High-Risk Early-Stage Breast Cancer

Affiliations

¹ Eugen Javor, MPharm, General Hospital Bjelovar, Bjelovar, Croatia; Marko Lucijanić, MD, PhD, Dubrava University Hospital, Zagreb, Croatia; and Marko Skelin, MPharm, PhD, General Hospital Šibenik, Šibenik, Croatia.

Comment

Eugen Javor et al. J Clin Oncol. 2020.

. 2020 Jun 20;38(18):2110.

doi: 10.1200/JCO.20.00091. Epub 2020 Apr 21.

¹ Eugen Javor, MPharm, General Hospital Bjelovar, Bjelovar, Croatia; Marko Lucijanić, MD, PhD, Dubrava University Hospital, Zagreb, Croatia; and Marko Skelin, MPharm, PhD, General Hospital Šibenik, Šibenik, Croatia.

No abstract available

Comment in

Reply to E. Javor et al.
Ambrosone CB, Hutson AD. Ambrosone CB, et al. J Clin Oncol. 2020 Jun 20;38(18):2111. doi: 10.1200/JCO.20.00546. Epub 2020 Apr 21. J Clin Oncol. 2020. PMID: 32315274 Free PMC article. No abstract available.

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).
Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS. Ambrosone CB, et al. J Clin Oncol. 2020 Mar 10;38(8):804-814. doi: 10.1200/JCO.19.01203. Epub 2019 Dec 19. J Clin Oncol. 2020. PMID: 31855498 Free PMC article. Clinical Trial.